We studied the roles of estrogen receptors (ER) and aromatase in the mediation of flow-induced dilation (FID) in isolated arteries of male ER knockout (ER -KO) and wild type (WT) mice.
INTRODUCTION
The presence of steroid hormone receptors in the vasculature has been recognized for some time (21) and the effect of the activation of vascular estrogen receptors (ERs) on genomic and nongenomic vascular responses in both sexes has been amply investigated (6) . A normal ER function is required for the cardiovascular development and function in both genders (17; 37) .
Recently, considerable attention has been directed to the issue of how cardiovascular tissues in males respond to the exposure of estrogen. A key enzyme responsible for conversion of androgen to estrogen in males is aromatase, a member of the cytochrome P450 (CYP) superfamily of enzymes. In males, multiple tissues are involved in the aromatization of testosterone to form estradiol, including the testes, liver, muscle, skin and adipose tissue (1) , as well as vascular smooth muscle and endothelial cells (7; 30) . Increasing evidence has been provided that estrogen has beneficial effects on the male cardiovascular system of humans and animals (22) . Recent studies highlight the significance of aromatase-derived estrogen in the regulation of endothelial function in the male vasculature. A reduction of endogenous estrogen via aromatase inhibition significantly decreases flow-induced dilation of brachial arteries in healthy young men (19) . In male aromatase-knockout mice, which are incapable of synthesizing estrogen, acetylcholine-stimulated release of nitric oxide (NO) is significantly decreased compared to wild type controls (18) . Thus, aromatase has been defined as an estrogen-producing enzyme in vasculature (7) , and has been shown to be essential for the maintenance of normal endothelial function in male vessels (33) . Estrogens generated in the male vasculature initiate regulatory functions via activating estrogen receptors (ERs) that are located in both smooth muscle and endothelial cells (26; 34) . The role of ER in the estrogen-dependent potentiation of NO synthesis has been well established (8; 29) . Men lacking functional ER were reported to R-00185-2007 5 have early coronary arterial calcification, as well as impairment of endothelial function (31; 32) .
Specifically, the variation in the gene for ER , such as with the CC genotype at c.454-397CC or c.454-397T>C was demonstrated to be associated with an increased risk of myocardial infarction in men (28) .
Given that estrogen is necessary for the maintenance of endothelial function in the male vasculature and that ERs are required for the mediation of vascular responses, it is legitimate to hypothesize that the release of NO from vessels in response to shear stress is reduced in ER knockout (ER -KO) mice. Also, it remains of interest to seek an answer to the question whether and by what mechanisms, estrogen exerts a beneficial effect on endothelial mechanotransduction to shear stress in the absence of its specific receptor, a target which has been shown to be necessary in estrogen-induced NO production. Thus, our studies were conducted on isolated and cannulated gracilis muscle and mesenteric arteries of male ER -KO and wild type (WT) mice.
Shear stress-induced arterial dilations and the mediators responsible for the responses were assessed. The data obtained validate our hypothesis that an attenuated NO-mediated portion of flow-induced responses, caused by ER deficiency, is compensated for by endothelium derived hyperpolarizing factor(s) (EDHF), identified as epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid via CYP, leading to a normal vasodilator response to shear stress.
METHODS
12-14 week-old male ER -KO and WT (C57BL/BNT) mice were purchased from Taconic Farms, Inc. All protocols were approved by the Institutional Animal Care and Use Committee of New York Medical College and conform to the current National Institutes of Health and American Physiological Society guidelines for the use and care of laboratory animals.
Isolated arteries
Mice were sacrificed by inhalation of 100% CO 2 . Experiments were conducted on arteries isolated from either gracilis muscle or mesentery because of the identical features of their flow-induced dilations, as well as the mediators responsible for the responses (10; 11; 13; 14; 36).
The first-order gracilis muscle arteries were isolated for experiments of flow-induced dilation. In experiments of membrane potential measurement, donor vessels were isolated from first-order gracilis muscle arteries of ER -KO and WT mice. Second-order mesenteric arteries of the corresponding animals were used as detector vessels. The endothelium of the detector vessel was removed by injection of air into the vessel lumen as described previously (10; 11). RNA interference study was performed on second-order mesenteric arteries of ER -KO mice because they have adequate length with fewer branches. Also, a sufficient number of vessels can be obtained from the mesentery for RT-PCR and western blotting analysis, after transfection with specific siRNA.
Flow/shear stress-induced dilation Changes in diameter of arteries in response to increases in perfusate flow (from 0 to 10 µL/min, in 2 µL/min steps) were studied at 80 mmHg of perfusion pressure.
Firstly, roles of NO and prostaglandins (PGs) in flow-induced dilation were assessed by exposure of vessels to N -nitro-L-arginine methyl ester (L-NAME, 3x10 -4 M) and indomethacin (INDO, 10 -5 M), inhibitors of nitric oxide synthase (NOS) and cyclooxygenase (COX), respectively, after control flow-diameter curves were obtained.
Next, the role of metabolites of CYP/epoxygenase in the mediation of the L-NAME/INDO resistant portion of flow-induced dilation was assessed by using 6-(2-proparglyoxyphenyl)hexanoic acid (PPOH, 5x10 -5 M), an inhibitor of CYP/epoxygenase (10) responsible for metabolizing arachidonic acid to EETs.
Last, contribution of potassium channels to PPOH-sensitive flow-induced dilations was evaluated by administration of iberiotoxin (IBTX, 2x10 -7 M), a blocker of large conductance
Assessment of smooth muscle membrane potential of detector vessels Similar to what was described previously (11), the membrane potential of an endothelium-denuded mesenteric artery (detector vessel) in response to the perfusate that had flown through a 10 dyne/cm 2 -stimulated gracilis artery (donor vessel) was recorded. Briefly, a donor vessel was cannulated in chamber A, an endothelium-denuded detector vessel was cannulated in chamber B that was connected serially by a micropipette (~2µl volume) to the outflow site of chamber A. Thus, when shear stress was initiated by perfusion of the donor vessel, the perfusate flowed through the detector vessel in which changes in membrane potential and diameter were simultaneously recorded.
Intraluminal pressure of the two vessels was maintained at 80 mmHg. 
Calculations and statistics Changes in diameter in responses to increases in flow in each vessel
were normalized to its passive diameter (PD). Statistical significance was calculated by repeated measures of analysis of variance (ANOVA) followed by Tukey/Kramer multiple-comparison test. Data are presented as the mean ± standard error of mean. N is the number of mice. A group t-test was also used in comparison of two independent groups, such as data of GC/MS and molecular studies, etc. Significance level was taken at p < 0.05.
RESULTS
The characteristics of isolated arteries from male WT (N=9-12) and ER -KO (N=16-8) mice are summarized in Table 1 . Active diameter of arteries of ER -KO mice obtained in the presence of 80 mmHg intravascular pressure was significantly smaller than in WT mice. In the same conditions but in Ca
2+
-free solution, the passive diameter of arteries of each group was comparable.
As a result, the basal tone, expressed as a percentage of passive diameters was increased in arteries of ER -KO compared to WT mice (P=0.087). Inhibition of NO, prostaglandins and EETs with L-NAME, INDO and PPOH, did not affect basal tone of either group of vessels, but inhibition of potassium channels with IBTX significantly enhanced basal tone in arteries of ER -KO mice. Changes in diameter and membrane potential of detector vessels in response to the perfusate flowing through L-NAME/INDO-treated donor vessels stimulated by shear stress were recorded, in order to examine whether the EETs that are released from ER -KO donor vessels would not only dilate, but also hyperpolarize detector vessels. The resting membrane potential of detector vessels of ER -KO mice was comparable to that of WT mice (panel a and Table 1 ). In the presence of 10 dyne/cm 2 shear stress, the perfusate passing through donor vessels elicited smooth muscle hyperpolarization of detector vessels by -12.00 ± 2.2 mV (panel b), associated with increases in diameter by 13.2 ± 1.4 µm (panel c), suggesting that the mediators released from shear stress-stimulated donor vessels hyperpolarize and dilate detector vessels. The hyperpolarization and dilation were eliminated when the donor vessels were exposed to PPOH, or the detector vessels to IBTX, suggesting that it is EETs released from donor vessels that activate BK Ca channels on vessels. However, applying the same level of shear stress to L-NAME/INDO-treated donor vessels isolated from WT mice did not significantly affect the resting membrane potential (-26.8 ± 3.5 vs -25.0 ± 2.4mV) or basal diameter (87.3 ± 3.4 vs 87.0 ± 3.2µm) of detector vessels.
Western blot analysis in Figure 3 shows a significant reduction of eNOS expression 
DISCUSSION
This is the first study to investigate effects of a deficiency of ER on arterial regulation of shear stress in male mice. We demonstrated that flow/shear stress-induced dilation in male ER -KO arteries is well maintained via an EDHF/EET-mediated mechanism compensating for an impaired NO-mediated response, as a function of estrogen aromatized from testosterone.
EET/EDHF mediates flow-induced dilations in arteries of male ER -KO mice: ER is necessary
for both genomic and nongenomic enhancement of NO synthesis in the vasculature of both genders (9) . This was also proven by our present findings showing that in arteries of ER deficient mice, the NO-mediated portion of flow-induced dilation was significantly attenuated (Figure 1c) , as a consequence of reduced eNOS expression (Figure 3a) . We also found that eNOS phosphorylation was not significantly different in vessels of ER -KO and WT mice, as indicated by a comparable ratio of phospho-eNOS versus eNOS in the two groups (data not shown). Indeed, in response to ER deficiency, the vascular production of NO is significantly impaired in both humans and animals (4; 31; 32). On the other hand, a role for estrogen in the regulation of vascular endothelial function in males has also been proven, since the beneficial effect of testosterone on the vasculature is dependent upon the presence of aromatase (18; 19; 22) . For example, castration of male LDL receptor knockout mice hastens the development of atherosclerosis compared to intact mice, while inhibition of aromatase in intact mice reverses the protective effect of testosterone to the level observed in castrated animals (24) , indicating that testosterone can prevent the development of atherosclerosis by its conversion to estradiol by aromatase. Since our previous studies demonstrated the beneficial effect of estrogen on augmenting NO-mediated flow/shear stress-induced dilations in gracilis muscle arteries of mice and rats (9; 12), we originally assumed that ER -KO arteries would have reduced flow-induced dilation, due to a reduction of NO release. However, the results obtained were contrary to our expectation in that ER -KO and WT mice have a comparable magnitude of flow-induced dilation in (Figure 1a-c) .
Subsequent studies were focused on the issue as to what is the mechanism(s) responsible for the preserved endothelial regulation of shear stress, and whether estrogen evokes beneficial effects via an ER -independent pathway in male ER -KO arteries. We found, as observed previously (10; 36) , that in arteries of WT mice, NO and PGs participate equally in the mediation of flow-induced dilation (Figure 1b) . In arteries of ER -KO mice however, L-NAME had a lesser effect on flow-induced dilation than in those of WT controls (~26% vs 50%).
Additional INDO maintained its inhibitory effect (by ~50%), leaving a portion (~24%) of the dilation that is resistant to L-NAME and INDO (Figure 1c and d) . By using a specific inhibitor of CYP/epoxygenase, the nature of the mediator was characterized as EETs. Also, the specific target of EETs was identified as K Ca -channels on smooth muscle, since EDHF bioassay studies
show that in the presence of 10 dyne/cm 2 shear stress in donor vessels, increasing hyperpolarization and vasodilation of detector vessels were elicited in response to the perfusate flowing through donor vessels that had been treated with L-NAME and INDO. This could be prevented by blocking K Ca channels in detector vessels, or by inhibiting EET synthesis in donor vessels ( Figure 2 ). Thus, it is EETs that mediate the L-NAME/INDO-resistant portion of flowinduced dilation in arteries of male ER -KO mice. These results strongly support our conclusions that EETs are the EDHF in arteries of rats and mice (10; 11; 13; 14) .
Mechanism responsible for the female phenotypic flow-induced responses in male ER -KO mice.
Our previous studies demonstrated that in NO deficiency, EDHF/EET is responsible for the mediation of endothelium-dependent, flow/shear stress-induced dilation of arteries from female, but not from arteries of male mice and rats, a response that is purely estrogen-and estrogen receptor-dependent (10; 11; 13; 36), and therefore, has been characterized as a female phenotypic response Thus, the present study showing an EET/EDHF-mediated flow/shear stressinduced dilation in male ER -KO mice seems to challenge our previous conclusions. With respect to the puzzling emergence of a female phenotypic flow-induced response in male mice, two issues need to be borne in mind, namely the relationship between NO and EDHF/EETs, and the role of estrogen in the response.
In physiological conditions, the contribution of EDHF to the regulation of vascular tone is compromised by the presence of NO, as indicated by the fact that shear stress-stimulated release of EETs from arteries is only observed when NO synthesis is absent or impaired (9-11; 13; 36), suggesting a negative correlation between NO and CYP/EDHF. Indeed, as we demonstrated in ER -KO mice, protein expression of eNOS in arteries were significantly reduced (Figure 3a) , whereas, arterial production of EETs was significantly increased (Figure 4 ).
These data are consistent with our functional results showing a switch from NO-mediation to the mediation by EETs (Figure 1c and d) , and provide molecular and biochemical evidence that forms the basis of EET-mediated dilation to shear stress in compensation for a reduced ERrelated release of NO. Although CYP-mediation of flow-induced dilation in arteries/arterioles is a genomic response, as indicated by the fact that the response was prevented by transcriptional inhibitors (13), the specific CYP gene(s) responsible for the upregulation of EET synthesis in microvessels has not yet been identified. The identification of the specific gene(s) screened from CYP global genes (more than 500 genes categorized in 78 faminlies) will require microarray analysis.
The mechanism responsible for the compensatory upregulation of EETs/EDHF-mediated dilator pathway elicited by shear stress has been demonstrated to be an estrogen-dependent genomic response, since ovariectomy eliminated, and estrogen replacement restored the response, (13; 14) . In response to ER deficiency changes in ER receptor expression and aromatase activity needed to be addressed. Previous studies reported upregulation of ER during the process of vascular injury (20) . In the mediation of estrogen-dependent prevention of vascular diseases, ER and ER are able to complement one another (15; 16) and both mRNAs are upregulated by shear stress (23) . Similar to ER , ER binds specifically to estrogen responsive elements (ERE) and activates ERE-containing promoters in response to estrogen (25) .
We presumed therefore, that a compensatory upregulation of ER , in response to ER Regarding the specific role of estrogen in the responses, there is no significant change in circulating estradiol levels in male ER -KO mice, though there are unusually large increases in serum estradiol in female ER -KO mice (2; 3; 27) . However, there is increasing evidence that plasma estrogen levels may be a poor predictor of effective cellular estrogen concentrations, especially in the vasculature (35) . In males, estrogens, independent of plasma levels, are produced in significant quantities by local tissues through aromatization of testosterone (5; 7). In cultured vascular smooth muscle cells which express aromatase mRNA, exogenous administration of testosterone elicited a significant production of estradiol (7) . Thus, in the present study, the significantly increased concentrations of circulating testosterone in male ER -KO mice (27) provide extra amount of substrate to be aromatized, especially in the additional presence of an upregulated aromatase expression (Figure 3b) , to increase the local concentration of estradiol, that in turn, in a paracrine manner, can further upregulate vascular CYP and EET synthesis (Figure 4) (13). In order to confirm our conclusions and evaluate the specific effect of aromatase on the estrogen-dependent, EET-mediated dilator response to shear stress in vessels of male ER -KO mice, a short interfering RNA (siRNA) was used to knock down the aromatase gene in the vessels. In our previous studies, we have confirmed that EETs are the mediator of the dilation in response to shear stress in mesenteric, as well as gracilis arteries when NO and PGs are absent (11) . As an estrogen-producing enzyme in the vasculature, aromatase expression in ER -KO vessels was upregulated. We hypothesized therefore, that increased vascular estrogen aromatized from testosterone is responsible for this phenotypically female response in male ER -KO vessels. If this hypothesis is correct, the EET-mediated flow-induced dilation should be eliminated by knockdown of aromatase in the vessels. Thus, we designed an RNAi study, aimed to confirm whether the EET-mediated flow-induced response is aromatase dependent. EETmediated, shear stress-induced responses in these L-NAME/INDO treated-vessels were assessed before and after silencing the gene for aromatase. In the present study, a period of 72 hour transfection was chosen, based on the necessity for protein degradation. We found that aromatase siRNA specifically knocked down the gene (Figure 5b ) and protein expression (Figure 5c ) in the vessels, which was associated with the elimination of EET-mediated dilator response to shear control vessels was eliminated by an inhibitor of EET synthase and a BK Ca channel blocker, indicating that it is EETs that mediate shear stress-induced dilation/hyperpolarization in an aromatase-dependent manner. Thus, our results suggest that the cardiovascular protective effects of estrogen are not only of physiological importance in females, but also in males, since the male cardiovascular system is an important source, as well as a target, of estrogen.
In summary, our study provides evidence for the upregulation of aromatase and ER expressions in vessels of male ER -KO mice. We interpret our findings to mean that in male ER -KO mice, the high plasma testosterone and enhanced vascular activity of aromatase, increase significantly the vascular concentration of estradiol, a female hormone that is necessary for EET/EDHF-mediated flow/shear stress-induced dilation of arteries, when NO synthesis is impaired.
In addition, in view of the questions raised as to whether the maintenance of normal vascular tone by estrogen in males requires ERs, and whether estrogen's effect on vascular tone in males is mediated by NO, or some other autacoid (22) , our studies by using male ER -KO mice confirmed an association between estrogens and EDHF/EETs. Thus, a specific pathway is revealed by which aromatase-derived estrogen through ER regulates arterial endothelial function via upregulation of EET synthesis in the male vasculature to compensate for the impairment of NO synthesis.
GRANTS
This study was supported by NIH HL 070653, HL 68813 and HL 43023. BT with L-NAME + INDO + PPOH 63.5 ± 1. 
DISCLOSURES

